These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25186973)

  • 21. Clinical manifestations and genetic analysis of 4 children with chronic granulomatous disease.
    Guo C; Chen X; Wang J; Liu F; Liang Y; Yang J; Dai F; Ding N
    Medicine (Baltimore); 2020 Jun; 99(23):e20599. PubMed ID: 32502033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum level of KL-6 as a marker of interstitial lung disease in patients with juvenile systemic sclerosis.
    Veselý R; Vargová V; Ravelli A; Massa M; Oleksák E; D'Alterio R; Martini A; De Benedetti F
    J Rheumatol; 2004 Apr; 31(4):795-800. PubMed ID: 15088311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utility of screening for chronic granulomatous disease in patients with inflammatory bowel disease.
    Jaggi P; Scherzer R; Knieper R; Mousa H; Prasad V
    J Clin Immunol; 2012 Feb; 32(1):78-81. PubMed ID: 22089701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics of patients with primary Sjögren's syndrome associated interstitial lung disease and relevant features of disease progression.
    Zhang T; Yuan F; Xu L; Sun W; Liu L; Xue J
    Clin Rheumatol; 2020 May; 39(5):1561-1568. PubMed ID: 31902032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A therapeutic approach towards chronic granulomatous disease].
    Kawai T
    Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(6):437-46. PubMed ID: 25748127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging findings of pulmonary manifestations of chronic granulomatous disease in a large single center from Shanghai, China (1999-2018).
    Yao Q; Zhou QH; Shen QL; Qiao ZW; Wang XC; Hu XH
    Sci Rep; 2020 Nov; 10(1):19349. PubMed ID: 33168948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum B cell-activating factor (BAFF) level in connective tissue disease associated interstitial lung disease.
    Hamada T; Samukawa T; Kumamoto T; Hatanaka K; Tsukuya G; Yamamoto M; Machida K; Watanabe M; Mizuno K; Higashimoto I; Inoue Y; Inoue H
    BMC Pulm Med; 2015 Sep; 15():110. PubMed ID: 26424433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease.
    Avouac J; Cauvet A; Steelandt A; Shirai Y; Elhai M; Kuwana M; Distler O; Allanore Y
    PLoS One; 2020; 15(5):e0232978. PubMed ID: 32384128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An adult autosomal recessive chronic granulomatous disease patient with pulmonary Aspergillus terreus infection.
    Mortaz E; Sarhifynia S; Marjani M; Moniri A; Mansouri D; Mehrian P; van Leeuwen K; Roos D; Garssen J; Adcock IM; Tabarsi P
    BMC Infect Dis; 2018 Nov; 18(1):552. PubMed ID: 30409207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of lower-lobe interstitial lung disease on high-resolution computed tomography in patients with idiopathic pleuroparenchymal fibroelastosis.
    Kono M; Fujita Y; Takeda K; Miyashita K; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Enomoto N; Nakamura Y; Suda T; Nakamura H
    Respir Med; 2019; 154():122-126. PubMed ID: 31238182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Respiratory Complications Lead to the Diagnosis of Chronic Granulomatous Disease in Two Adult Patients.
    Colin de Verdière S; Noel E; Lozano C; Catherinot E; Martin M; Rivaud E; Couderc LJ; Salvator H; Bustamante J; Martin T
    J Clin Immunol; 2017 Feb; 37(2):113-116. PubMed ID: 28130637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fungal infection and increased mortality in patients with chronic granulomatous disease.
    Bassiri-Jahromi S; Doostkam A
    J Mycol Med; 2012 Mar; 22(1):52-7. PubMed ID: 23177814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomarkers to identify ILD and predict lung function decline in scleroderma lung disease or idiopathic pulmonary fibrosis.
    Kennedy B; Branagan P; Moloney F; Haroon M; O'Connell OJ; O'Connor TM; O'Regan K; Harney S; Henry MT
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Sep; 32(3):228-36. PubMed ID: 26422568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative diagnostic efficacy of serum Krebs von den Lungen-6 and surfactant D for connective tissue disease-associated interstitial lung diseases: A meta-analysis.
    Zhong D; Wu C; Bai J; Hu C; Xu D; Wang Q; Zeng X
    Medicine (Baltimore); 2020 Apr; 99(16):e19695. PubMed ID: 32311947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperinflammation in patients with chronic granulomatous disease leads to impairment of hematopoietic stem cell functions.
    Weisser M; Demel UM; Stein S; Chen-Wichmann L; Touzot F; Santilli G; Sujer S; Brendel C; Siler U; Cavazzana M; Thrasher AJ; Reichenbach J; Essers MAG; Schwäble J; Grez M
    J Allergy Clin Immunol; 2016 Jul; 138(1):219-228.e9. PubMed ID: 26853280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus.
    Morgenstern DE; Gifford MA; Li LL; Doerschuk CM; Dinauer MC
    J Exp Med; 1997 Jan; 185(2):207-18. PubMed ID: 9016870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary manifestations in adult patients with chronic granulomatous disease.
    Salvator H; Mahlaoui N; Catherinot E; Rivaud E; Pilmis B; Borie R; Crestani B; Tcherakian C; Suarez F; Dunogue B; Gougerot-Pocidalo MA; Hurtado-Nedelec M; Dreyfus JF; Durieu I; Fouyssac F; Hermine O; Lortholary O; Fischer A; Couderc LJ
    Eur Respir J; 2015 Jun; 45(6):1613-23. PubMed ID: 25614174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infections associated with chronic granulomatous disease: linking genetics to phenotypic expression.
    Ben-Ari J; Wolach O; Gavrieli R; Wolach B
    Expert Rev Anti Infect Ther; 2012 Aug; 10(8):881-94. PubMed ID: 23030328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infection Profile in Chronic Granulomatous Disease: a 23-Year Experience from a Tertiary Care Center in North India.
    Rawat A; Vignesh P; Sharma A; Shandilya JK; Sharma M; Suri D; Gupta A; Gautam V; Ray P; Rudramurthy SM; Chakrabarti A; Imai K; Nonoyama S; Ohara O; Lau YL; Singh S
    J Clin Immunol; 2017 Apr; 37(3):319-328. PubMed ID: 28332028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KL-6 is a long-term disease-activity biomarker for interstitial lung disease associated with polymyositis/dermatomyositis, but is not a short-term disease-activity biomarker.
    Hanaoka M; Katsumata Y; Kawasumi H; Kawaguchi Y; Yamanaka H
    Mod Rheumatol; 2019 Jul; 29(4):625-632. PubMed ID: 30484723
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.